Keywords and phrases: therapeutic, mathematical model, medicament, repaglinide, metformin, type 2 diabetes
Received: November 24, 2024; Revised: December 13, 2024; Accepted: January 23, 2025; Published: February 12, 2025
How to cite this article: Mahamat Saleh Daoussa Haggar, Jean Marie Ntaganda and Adam Hassan Adoum, A mathematical model for investigating the therapeutic response of repaglinide and metformin in type 2 diabetes patients, Far East Journal of Dynamical Systems 38(1) (2025), 107-125. https://doi.org/10.17654/0972111825005
This Open Access Article is Licensed under Creative Commons Attribution 4.0 International License  
References: [1] I. M. Tolic, E. Mosekilde and J. Sturis, Modeling the insulin-glucose feedback system: the significance of pulsatile insulin secretion, J. Theoret. Biol. 207 (2000), 361-375. https://doi.org/10.1006/jtbi.2000.2180. [2] Angus G. Jones, Beverley M. Shields, Richard A. Oram, Dana M. Dabelea, William A. Hagopian, Seth A. Sharp, Eva Lustigova, Amy S. Shah, Julieanne Knupp, Amy K. Mottl, Ralph B. D’Agostino Jr., Adrienne Williams, Santica M. Marcovina, Catherine Pihoker, Jasmin Divers and Maria J. Redondo, Clinical prediction models combining routine clinical measures have high accuracy in identifying youth-onset type 2 diabetes defined by maintained endogenous insulin secretion: the search for diabetes in youth study, Diabetes Care 47(12) (2024), 2110-2119. [3] Karl Sebastian Johansson, Espen Jimenez-Solem, Tonny Studsgaard Petersen and Mikkel Bring Christensen, Increasing medication use and polypharmacy in type 2 diabetes: the Danish experience from 2000 to 2020, Diabetes Care 47(12) (2024), 2120-2127. [4] Nick Oliver, Monika Reddy and Lala Leelarathna, Continuous glucose sensor accuracy: beyond the headline metric, The Lancet Diabetes and Endocrinology 12(12) (2024), 934-938. [5] K. Salih Mahdi, F. S. A. Alwan, I. J. Hasen and M. J. Al-Imari, Repaglinide and metformin (diabetic treatments) enhance sexual efficiency, International Journal of Health Sciences 6(S1) (2022), 6292-6308. [6] S. Kalra, A. K. Das, G. Priya, S. Ghosh, R. N. Mehrotra, S. Das, P. Shah, S. Bajaj, V. Deshmukh, D. Sanyal, S. Chandrasekaran, D. Khandelwal, A. Joshi, T. Nair, F. Eliana, H. Permana, M. D. Fariduddin, P. K. Shrestha, D. Shrestha, S. Kahandawa, M. Sumanathilaka, A. Shaheed, A. A. Rahim, A. Orabi, A. Al-Ani, W. Hussein, D. Kumar and K. Shaikh, Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel, J. Family Med. Prim Care 9(11) (2020), 5450-5457. [7] R. N. Bergman, D. T. Finegood and M. Ader, Assessment of insulin sensitivity in vivo, Endocrine Reviews 6(1) (1985), 45-86. [8] M. Derouich and A. Boutayeb, The effect of physical exercise on the dynamics of glucose and insulin, J. Biomech. 35(7) (2002), 911-917. [9] A. Roy and R. S. Parker, Dynamic modeling of free fatty acid, glucose, and insulin: an extended minimal model, Diabetes Technology and Therapeutics 8(6) (2006), 617-626. [10] A. De Gaetano and O. Arino, Mathematical modelling of the intravenous glucose tolerance test, J. Math. Biol. 40(2) (2000), 136-168. [11] J. Li, Y. Kuang and B. Li, Analysis of IVGTT glucose-insulin interaction models with time delay, Discrete Contin. Dyn. Syst. Ser. B 1(1) (2001), 103-124. [12] B. Topp, K. Promislow, G. Devries, R. M. Miura and D. T. Finegood, A model of - cell mass insulin, and glucose kinetics: pathways to diabetes, J. Theoret. Biol. 206(4) (2000), 605-619. [13] R. D. Hernandez, D. J. Lyles, D. B. Rubin, T. B. Voden and S. A. Wirkus, A model of cell mass insulin, glucose and receptor dynamics with applications to diabetes, Cornell University Department of Biological Statistics and Computational Biology Technical Report, BU-1579-M, 2001. [14] Jean Marie Ntaganda, Froduald Minani, Wellars Banzi, Lydie Mpinganzima, Japhet Niyobuhungiro, Vincent Dusabejambo, Immaculate Kambutse and Eric Rutaganda, Analysis of physical activity effects on plasma glucose-insulin system dynamics: a mathematical model, Transactions of the Institute of Measurement and Control 43(14) (2021), 3272-3281. [15] Wellars Banzi, Immaculate Kambutse, Vincent Dusabejambo, Eric Rutaganda, Froduald Minani, Japhet Niyobuhungiro, Lydie Mpinganzima and Jean Marie Ntaganda, Mathematical modelling of glucose-insulin system and test of abnormalities of type 2 diabetic patients, Int. J. Math. Math. Sci. 2021 (2021), Article ID 6660177. https://doi.org/10.1155/2021/6660177. [16] https://www.medbroadcast.com/drug/getdrug/mylan-metformin. Visited on 4th November 2024. [17] www.vidal.fr/medicaments/gammes/repaglinide-biogaran-48022.html. Visited on 4th November 2024. [18] Sorensen John Thomas, A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes, Ph. D. Thesis, Massachusetts Institute of Technology, 1985. [19] H. W. Engl, M. Hanke and A. Neubauer, Regularization of Inverse Problem, Kluwer Academic Publishers Group, Dordrecht, 1996. [20] M. Hanke, Iterative Regularization Techniques in Image Reconstruction, Surveys on Solution Methods for Inverse Problems, D. Colton et al., eds., Springer, Vienna, 2000, pp. 35-52. [21] S. Shamshirband, A. Malvandi, A. Karimipour, M. Goodarzi, M. Afrand, D. Petkovic, M. Dahari and N. Mahmoodian, Performance investigation of micro- and nano-sized particle erosion in a 90 elbow using an ANFIS model, Powder Technol. 284 (2015), 336-343.
|